Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-21
2011-06-21
Kosack, Joseph R (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S482000
Reexamination Certificate
active
07964628
ABSTRACT:
This invention relates to novel fused bicyclic compounds of the general formula (I):whereinthe symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.
REFERENCES:
patent: 3997572 (1976-12-01), Cusic et al.
patent: 7759387 (2010-07-01), Lal et al.
patent: 66175 (1969-04-01), None
patent: 0540334 (1993-05-01), None
patent: 0655439 (1995-05-01), None
patent: 1391451 (2004-02-01), None
patent: 989917 (1965-04-01), None
patent: 02085855 (2002-10-01), None
New, J. S. et al., “Buspirone analogues .2. Structure-activity relationships of aromatic imide derivatives,” J. Med. Chem. Amer. Chem. Soc. Washington, US, vol. 29, (8), 1986, pp. 1476-1482.
Sugimoto, H. et al., “Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivaties,” J. Med. Chem. Amer. Chem Soc., Washington, US, vol. 34 (24), 1992, pp. 4542-4548.
Gangopadhyay Ashok Kumar
Gole Gopal Vishnu
Gupte Ravindra Dattatraya
Krishnan Sridevi
Kulkarni-Almeida Asha
Kosack Joseph R
Piramal Life Sciences Limited
Volpe and Koenig P.C.
LandOfFree
Fibrinogen receptor antagonists and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2736618